Related Experiment Video
Updated: May 13, 2026
14:40
Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
Published on: October 27, 2020
From optogenetic technologies to neuromodulation therapies
Justin C Williams1, Timothy Denison
1Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA. jwilliams@engr.wisc.edu
Science Translational Medicine
|March 22, 2013
Summary
Optogenetics offers new insights into brain function and neuronal communication. This perspective examines the technical, practical, and regulatory challenges for translating optogenetic therapies into clinical use for neurological disorders.
Area of Science:
- Neuroscience
- Biotechnology
- Medical Technology
Background:
- Optogenetics has significantly advanced understanding of neuronal communication and brain function.
- There is considerable anticipation for clinical applications of optogenetics in treating neurological disorders.
Purpose of the Study:
- To highlight the key hurdles in translating optogenetics from research to clinical practice.
- To provide a perspective on the challenges facing optogenetic neuromodulation therapies.
Main Methods:
- This perspective analyzes existing literature and expert insights.
- It focuses on identifying technical, practical, and regulatory barriers.
Main Results:
- Significant technical challenges remain in the precise delivery and control of optogenetic tools.
- Practical considerations include long-term efficacy, safety, and patient-specific adaptations.
- Regulatory pathways for novel neuromodulation therapies are complex and require further development.
Conclusions:
- Overcoming these hurdles is crucial for realizing the therapeutic potential of optogenetics.
- Collaboration between researchers, clinicians, and regulatory bodies is essential.
- Successful translation requires addressing technical, practical, and regulatory challenges for optogenetic therapies.
